US Broker Ratings

Waters Corporation (WAT) Stock Analysis: Evaluating Growth Potential in Diagnostics & Research

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $22.99 billion and a robust..

Haleon plc (HLN) Stock Analysis: Evaluating a 15.72% Potential Upside for the UK Healthcare Giant

As investors navigate the volatile waters of the healthcare sector, Haleon plc (NYSE: HLN) emerges as an intriguing player with a substantial market capitalization of $45.11 billion. Positioned within the..

United Therapeutics Corporation (UTHR) Stock Analysis: Insights into a Healthcare Innovator with 2.19% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $22.94 billion,..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Powerhouse with an 18.22% Potential Upside

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is making significant strides in the diagnostics and research industry. With a market capitalization of $11.23 billion, Revvity offers..

Boston Scientific Corporation (BSX) Investor Outlook: 31% Upside Potential Amid Robust Revenue Growth

Boston Scientific Corporation (NYSE: BSX), a leading player in the medical devices industry, presents a compelling investment opportunity with a notable 31.02% potential upside, according to analyst ratings. With a..

Veeva Systems Inc. (VEEV) Stock Analysis: A 38.96% Potential Upside Attracts Investors

Investors eyeing opportunities in the healthcare technology sector might find Veeva Systems Inc. (NYSE: VEEV) an intriguing prospect. As a cloud-based software provider specializing in solutions for the life sciences..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating Its 4.61% Dividend Yield and Growth Outlook

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $111.23 billion, BMY has established..

Cencora, Inc. (COR) Stock Analysis: Exploring a 13.75% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, particularly in medical distribution, is capturing investor attention with a significant market cap of $66.16 billion. As the company..

Baxter International Inc. (BAX) Stock Analysis: Navigating a Challenging Landscape with a 22% Potential Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is at a pivotal juncture as it navigates a challenging financial landscape. With a market capitalization of $9.96 billion,..

Novartis AG (NVS) Stock Analysis: Navigating a Stable Path Amidst Healthcare Giants

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, continues to draw investor attention with its robust market position and expansive pharmaceutical portfolio. Headquartered in Basel, Switzerland, Novartis..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Navigating a 14% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, stands out for investors seeking exposure to the pharmaceutical industry. With a market capitalization of $52.08 billion,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Discovering a 23.89% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is capturing investor attention with its robust growth potential and strategic position in the healthcare sector. With a market cap of $14.48 billion, this San..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Insulet Corporation (PODD) Stock Analysis: Robust Analyst Ratings Signal a Promising 30.87% Upside

Insulet Corporation (NASDAQ: PODD) is a prominent player in the healthcare sector, focusing on innovative medical devices. With a market capitalization of $20.32 billion, the company is known for its..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Powerhouse with a Promising 3.99% Upside

Cardinal Health, Inc. (NYSE: CAH) stands out as a stalwart in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $49.49 billion, Cardinal Health..

Natera, Inc. (NTRA) Investor Outlook: Analysts Back Diagnostics Leader with a 5.36% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with its innovative molecular testing services. Headquartered in Austin, Texas, Natera..

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 19.96% Potential Upside for Investors

As an iconic name in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) stands at the forefront of health technology, offering a diverse portfolio that spans diagnostic imaging, connected care,..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring an 18% Upside Potential

Labcorp Holdings Inc. (NYSE: LH) presents an intriguing opportunity for investors with its strong position in the healthcare sector, particularly within the diagnostics and research industry. As a key player..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating a Robust Biotech with 1.33% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leading player in the biotechnology sector, is capturing investor attention with its robust portfolio of medicines and innovative research initiatives. With a market capitalization..

Centene Corporation (CNC) Investor Outlook: Navigating Healthcare Challenges with a $19.91 Billion Market Cap

Centene Corporation (NYSE: CNC), a key player in the healthcare sector, continues to navigate a complex landscape as a provider of healthcare plans in the United States. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds